142 related articles for article (PubMed ID: 19174531)
1. Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk.
Borzsei R; Mark L; Tamas A; Bagoly T; Bay C; Csanaky K; Banki E; Kiss P; Vaczy A; Horvath G; Nemeth J; Szauer E; Helyes Z; Reglodi D
Eur J Endocrinol; 2009 Apr; 160(4):561-5. PubMed ID: 19174531
[TBL] [Abstract][Full Text] [Related]
2. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) in the plasma and milk of ruminant animals.
Czegledi L; Tamas A; Borzsei R; Bagoly T; Kiss P; Horvath G; Brubel R; Nemeth J; Szalontai B; Szabadfi K; Javor A; Reglodi D; Helyes Z
Gen Comp Endocrinol; 2011 May; 172(1):115-9. PubMed ID: 21185294
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide concentrations in the sheep mammary gland, milk, and in the lamb blood plasma after suckling.
Pohóczky K; Tamás A; Reglődi D; Kemény Á; Helyes Z; Czeglédi L
Physiol Int; 2020 Mar; 107(1):92-105. PubMed ID: 32491290
[TBL] [Abstract][Full Text] [Related]
4. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
[TBL] [Abstract][Full Text] [Related]
5. Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry.
Brubel R; Reglodi D; Jambor E; Koppan M; Varnagy A; Biro Z; Kiss P; Gaal V; Matkovits A; Farkas J; Lubics A; Bodis J; Bay C; Veszpremi B; Tamas A; Nemeth J; Mark L
J Mass Spectrom; 2011 Feb; 46(2):189-94. PubMed ID: 21259400
[TBL] [Abstract][Full Text] [Related]
6. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
7. Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation.
Csanaky K; Banki E; Szabadfi K; Reglodi D; Tarcai I; Czegledi L; Helyes Z; Ertl T; Gyarmati J; Szanto Z; Zapf I; Sipos E; Shioda S; Tamas A
J Mol Neurosci; 2012 Nov; 48(3):631-7. PubMed ID: 22539193
[TBL] [Abstract][Full Text] [Related]
8. Presence of pituitary adenylate cyclase activating polypeptide and its type I receptor in the rat kidney.
Brubel R; Horvath G; Reglodi D; Lubics A; Tamas A; Kiss P; Laszlo E; Nemeth J; Mark L; Szakaly P
Transplant Proc; 2011 May; 43(4):1297-9. PubMed ID: 21620115
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
10. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase-activating polypeptide (PACAP) in the hypothalamic-pituitary-gonadal axis: a review of the literature.
Thomas RL; Crawford NM; Grafer CM; Halvorson LM
Reprod Sci; 2013 Aug; 20(8):857-71. PubMed ID: 23232965
[TBL] [Abstract][Full Text] [Related]
12. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
13. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
14. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.
Mounien L; Do Rego JC; Bizet P; Boutelet I; Gourcerol G; Fournier A; Brabet P; Costentin J; Vaudry H; Jégou S
Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705
[TBL] [Abstract][Full Text] [Related]
16. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H
Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
